TIDMAKT

RNS Number : 9956K

Ark Therapeutics Group PLC

01 July 2014

ARK THERAPEUTICS GROUP PLC

Results of Annual General Meeting

Board Changes

Transaction Update

London, UK, 1 July 2014 (LSE: AKT): At the Annual General Meeting of Ark Therapeutics Group plc ("Ark" or the "Company") held yesterday all resolutions as set out in the Notice of Meeting dated 29 May 2014 were duly passed. A summary of the proxy voting will be published in the Investor Relations section of the Company's website at www.arktherapeutics.com.

A copy of the approved resolutions has been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM

The Company also announces the retirement of Charles Spicer as a Non-Executive Director with effect from the Annual General Meeting. The Board of Ark offers its thanks to Mr Spicer for the contribution he has made to the Company and wishes him success in his other continuing business interests.

The Company is also pleased to announce the appointment of Sue Steven as a Non-Executive Director of the Company with effect from 30 June 2014. Mrs Steven has worked with Ark for over 10 years, having been an employee of the Company prior to the disposal of its trading subsidiaries in March 2013, and consequently has an in-depth knowledge of the Company. Mrs Steven currently acts as Ark's Company Secretary and will continue in that role alongside her directorship. Prior to joining Ark, Mrs Steven held a number of managerial roles within a wide range of sectors, including legal, 3G mobile communications, computing and animal healthcare.

The Company confirms that there is no information to disclose in relation to Listing Rule 9.6.13 in respect of Mrs Steven.

Finally on behalf of the Board, Iain Ross, Chairman stated: "Further to the announcement made on 28 March 2014 concerning a possible "reverse" transaction I can confirm that all matters in connection with this transaction are progressing well and the Board will send further information to shareholders in due course."

For further information please contact:

 
             Ark Therapeutics Group plc            Tel: +44(0)203 755 5160 
             Iain G Ross, Non-Executive Chairman 
             David Venables, Non-Executive 
              Director

This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding Ark's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond Ark's control that could cause the actual results, performance or achievements of Ark to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Ark's present and future business strategies and the environment in which Ark will operate in the future. These forward-looking statements speak only as at the date of this announcement. Ark expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Ark's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCQKKDBKBKBPAN

Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Premier Veterinary Charts.
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Premier Veterinary Charts.